Marimed (MRMD) Operating Margin (2011 - 2026)

Marimed (MRMD) has 16 years of Operating Margin data on file, last reported at 0.32% in Q1 2026.

• On a quarterly basis, Operating Margin rose 272.0% year-over-year to 0.32% in Q1 2026; TTM through Mar 2026 was 1.03%, a 98.0% decrease from a year earlier, with the FY2025 full-year figure at 1.76%, down 342.0% from the prior year.
• Operating Margin for Q1 2026 stood at 0.32%, up from 10.86% in the prior quarter.
• Over the last five years, Operating Margin for MRMD reached as high as 22.53% in Q1 2022 and fell as low as 10.86% in Q4 2025.
• Historically, Operating Margin has averaged 6.01% across 5 years, with a median of 5.33% in 2024.
• On a YoY basis, Operating Margin climbed as much as 475 bps in 2022 and fell as far as 2322 bps in 2022.
• Year by year, Operating Margin stood at 8.62% in 2022, then retreated by 28 bps to 6.2% in 2023, then sank by 161 bps to 3.77% in 2024, then slumped by 188 bps to 10.86% in 2025, then surged by 103 bps to 0.32% in 2026.
• Per Business Quant data, the three most recent Operating Margin figures were 0.32% in Q1 2026, 10.86% in Q4 2025, and 3.92% in Q3 2025.